| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |